ZA892998B - Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having improved core membrane adhesion properties - Google Patents

Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having improved core membrane adhesion properties

Info

Publication number
ZA892998B
ZA892998B ZA892998A ZA892998A ZA892998B ZA 892998 B ZA892998 B ZA 892998B ZA 892998 A ZA892998 A ZA 892998A ZA 892998 A ZA892998 A ZA 892998A ZA 892998 B ZA892998 B ZA 892998B
Authority
ZA
South Africa
Prior art keywords
pharmaceutically acceptable
active agent
delivery system
system containing
oral delivery
Prior art date
Application number
ZA892998A
Other languages
English (en)
Inventor
Shailesh B Shah
B Shah Shailesh
Arun Dattatreya Koparkar
Dattatreya Koparkar Arun
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of ZA892998B publication Critical patent/ZA892998B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Confectionery (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • External Artificial Organs (AREA)
ZA892998A 1988-04-25 1989-04-24 Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having improved core membrane adhesion properties ZA892998B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/185,564 US4892739A (en) 1988-04-25 1988-04-25 Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties

Publications (1)

Publication Number Publication Date
ZA892998B true ZA892998B (en) 1989-12-27

Family

ID=22681522

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA892998A ZA892998B (en) 1988-04-25 1989-04-24 Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having improved core membrane adhesion properties

Country Status (22)

Country Link
US (1) US4892739A (xx)
EP (1) EP0339506B1 (xx)
JP (1) JP2750150B2 (xx)
KR (1) KR0125935B1 (xx)
AT (1) ATE75939T1 (xx)
AU (1) AU618083B2 (xx)
CA (1) CA1334382C (xx)
DD (1) DD288093A5 (xx)
DE (1) DE58901373D1 (xx)
DK (1) DK175232B1 (xx)
ES (1) ES2031302T3 (xx)
FI (1) FI90203C (xx)
GR (1) GR3005399T3 (xx)
HU (1) HU201469B (xx)
IE (1) IE61223B1 (xx)
IL (1) IL90019A (xx)
MX (1) MX15754A (xx)
NO (1) NO175186C (xx)
NZ (1) NZ228845A (xx)
PH (1) PH27150A (xx)
PT (1) PT90341B (xx)
ZA (1) ZA892998B (xx)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023076A (en) * 1987-02-27 1991-06-11 Alza Corporation Lamina comprising carboxyvinyl polymer
US5156850A (en) * 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
US5232705A (en) * 1990-08-31 1993-08-03 Alza Corporation Dosage form for time-varying patterns of drug delivery
US6764697B1 (en) * 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
US8524277B2 (en) * 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6099862A (en) 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
SE0003125D0 (sv) * 2000-09-05 2000-09-05 Astrazeneca Ab Modified polymers
MXPA03003994A (es) 2000-11-03 2004-09-10 Andrx Labs Llc Composiciones de metformina de liberacion controlada.
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
US6790459B1 (en) 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin
US6610326B2 (en) * 2001-02-16 2003-08-26 Andrx Corporation Divalproex sodium tablets
ATE477795T1 (de) * 2001-07-04 2010-09-15 Sun Pharma Advanced Res Co Ltd Magenretentionssystem mit kontrollierter arzneimittelfreisetzung
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
US20040052848A1 (en) * 2002-05-23 2004-03-18 Xiu-Xiu Cheng Biguanide formulations
US20050051922A1 (en) * 2002-09-20 2005-03-10 Avinash Nangia Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
US20050048119A1 (en) * 2002-09-20 2005-03-03 Avinash Nangia Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
KR101363679B1 (ko) 2002-09-20 2014-02-14 안드렉스 랩스 엘엘씨 약제학적 정제
AU2003903507A0 (en) * 2003-07-08 2003-07-24 U. S. Filter Wastewater Group, Inc. Membrane post-treatment
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US20050196448A1 (en) * 2004-03-05 2005-09-08 Hai Yong Huang Polymeric compositions and dosage forms comprising the same
US20050196447A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
MXPA06010003A (es) * 2004-03-05 2007-03-21 Johnson & Johnson Composiciones polimericas y formas de dosificacion que comprenden las mismas.
US20050196442A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196446A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050287185A1 (en) * 2004-06-23 2005-12-29 David Wong Extended release oxybutynin formulation
US8524794B2 (en) * 2004-07-05 2013-09-03 Siemens Industry, Inc. Hydrophilic membranes
IL166114A0 (en) * 2005-01-03 2006-01-15 Calcident Active Ltd Long-acting controlled-release pharmaceutical preparation for use in the oral cavity
CN102670555A (zh) * 2011-03-14 2012-09-19 北京天衡药物研究院 富马酸美托洛尔渗透泵控释片
CN102670539A (zh) * 2011-03-14 2012-09-19 北京天衡药物研究院 琥珀酸美托洛尔渗透泵控释片
CN104684632A (zh) 2012-09-14 2015-06-03 伊沃夸水处理技术有限责任公司 用于膜的聚合物共混物
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
CN107847869B (zh) 2015-07-14 2021-09-10 罗门哈斯电子材料新加坡私人有限公司 用于过滤系统的通气装置
EP3826619A1 (de) * 2018-07-24 2021-06-02 Bayer Aktiengesellschaft Oral applizierbare pharmazeutische darreichungsform mit modifizierter freisetzung
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
JP2023541448A (ja) * 2020-09-15 2023-10-02 シンアジャル コーポレイション 薬物を口の中へ連続的に押し出すためのデバイス及び方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4439195A (en) * 1980-10-14 1984-03-27 Alza Corporation Theophylline therapy
US4326525A (en) * 1980-10-14 1982-04-27 Alza Corporation Osmotic device that improves delivery properties of agent in situ
US4455143A (en) * 1982-03-22 1984-06-19 Alza Corporation Osmotic device for dispensing two different medications
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
EP0153105B1 (en) * 1984-02-10 1992-09-09 Benzon Pharma A/S Diffusion coated multiple-units dosage form
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom
US4693886A (en) * 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
ES2032205T3 (es) * 1986-11-14 1993-01-16 Ciba-Geigy Ag Procedimiento para la obtencion de un sistema osmotico oral para la administracion de metoprolol.

Also Published As

Publication number Publication date
GR3005399T3 (xx) 1993-05-24
DK196189A (da) 1989-10-26
KR900015734A (ko) 1990-11-10
FI891921A0 (fi) 1989-04-21
DE58901373D1 (de) 1992-06-17
US4892739A (en) 1990-01-09
IL90019A0 (en) 1989-12-15
EP0339506A1 (de) 1989-11-02
NO891680L (no) 1989-10-26
DD288093A5 (de) 1991-03-21
AU3268789A (en) 1989-10-26
IE61223B1 (en) 1994-10-19
JP2750150B2 (ja) 1998-05-13
FI90203C (fi) 1994-01-10
PT90341A (pt) 1989-11-10
EP0339506B1 (de) 1992-05-13
NO175186B (xx) 1994-06-06
DK175232B1 (da) 2004-07-19
MX15754A (es) 1994-01-31
DK196189D0 (da) 1989-04-24
NO175186C (no) 1994-09-14
CA1334382C (en) 1995-02-14
FI891921A (fi) 1989-10-26
PT90341B (pt) 1994-08-31
ATE75939T1 (de) 1992-05-15
JPH029815A (ja) 1990-01-12
IE891316L (en) 1989-10-25
NZ228845A (en) 1990-10-26
ES2031302T3 (es) 1992-12-01
HU201469B (en) 1990-11-28
HUT50625A (en) 1990-03-28
AU618083B2 (en) 1991-12-12
FI90203B (fi) 1993-09-30
PH27150A (en) 1993-04-02
IL90019A (en) 1994-04-12
KR0125935B1 (ko) 1997-12-26
NO891680D0 (no) 1989-04-24

Similar Documents

Publication Publication Date Title
ZA892998B (en) Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having improved core membrane adhesion properties
AU1534699A (en) Osmotic dosage form comprising first and second coats
GR1002564B (el) Στερεα απο του στοματος χορηγουμενη φαρμακευτικη μορφη δοσιμετρησεως προγραμματισμενου ρυθμου απελευθερωσεως.
ZA912380B (en) Osmotic dosage system for liquid drug delivery
DE69229949D1 (de) Diltiazem enthaltende arzneimittel mit verzögerter wirkstoffabgabe
HUP9801526A2 (hu) Inhaláló berendezés albuterol adagolására mért dózisban
EP0572942A3 (en) Oral pharmaceutical compositions for specific colon delivery
IL142474A0 (en) Pharmaceutical formulation comprising omeprazole
IL143900A0 (en) Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
WO1997014806A3 (en) Delivery of biologically active polypeptides
IL146818A0 (en) New formulation
NZ509028A (en) Stable extended release oral dosage composition comprising a pseudoephedrine-containing core, the core being uniformly covered with a desloratadine-containing film
EP0667148A4 (en) PERORAL PHARMACEUTICAL PREPARATION WITH RELEASE IN THE LOWER DIGESTIVE TRACT.
ZA9710093B (en) Water soluble film for oral administration with instant wettability.
GEP20033014B (en) Enteric Coated Pharmaceutical Composition and Method of Manufacturing
ES8800836A1 (es) Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.
ES8705223A1 (es) Procedimiento para la obtencion de una composicion retardada a base de bromocriptina.
ES2007040A6 (es) Un forma de dosificacion para descargar un agente benificioso a un entorno fluido de uso
JO1881B1 (en) Formula II for multi unit disc calibration